Editor's Note: The lead story in the November 25, 2016 issue of LIR is about changes to the 2017 Clinical Laboratory Fee Schedule affecting reimbursement for clinical laboratory tests. The … [Read more...]
FEE SCHEDULES
CORRECTION: Molecular Assays Stave Off Big Cuts in 2017 Clinical Laboratory Fee Schedule
May 17, 2017
FEE SCHEDULES
2017 Clinical Laboratory Fee Schedule: The 3 Changes Affecting Your Reimbursement
November 25, 2016
The Centers for Medicare and Medicaid Services (CMS) issued the final 2017 Clinical Laboratory Fee Schedule (CLFS) on Nov. 21. The winners: The small group of labs that provide new specialty molecular … [Read more...]
FEE SCHEDULES
Crosswalked Codes in 2017 Clinical Laboratory Fee Schedule
November 7, 2016
CPT Code Crosswalked To 80305 (Drug tests(s), presumptive, any number of drug classes; any number of devices or procedures, (e.g., immunoassay) capable of being read by direct optical … [Read more...]
FEE SCHEDULES
Are Commercial Payers Citing Proposed CMS Gapfill Rates, Trying to Negotiate Lower Reimbursement?
September 22, 2016
During the summer, the Centers for Medicare & Medicaid Services (CMS) published proposed interim gapfill prices for 15 molecular tests. The agency said it would likely publish final prices later … [Read more...]
ENFORCEMENT
CMS Bars Theranos’ California Lab from Medicare Program
July 21, 2016
Elizabeth Holmes dropped out of college to start up Theranos. Now Theranos and Holmes have been dropped from the Medicare program. Theranos has confirmed that the Centers for Medicare & Medicaid … [Read more...]
ENFORCEMENT
CMS Scrutiny Continues for Theranos
April 18, 2016
By Ron Shinkman, Editor, Laboratory Industry Report The Theranos saga has just entered its most critical state, as the Centers for Medicare & Medicaid Services (CMS) recommended the company's … [Read more...]
Two Prominent Senators Push CMS to Make Changes on PAMA Rules
February 1, 2016
The Congressional pressure on the Centers for Medicare & Medicaid Services to make changes to its proposed final rules on the Protecting Access to Medicare Act (PAMA) have been ramped up, with two … [Read more...]
Two Prominent Senators Push CMS to Make Changes on PAMA Rules
January 21, 2016
The Congressional pressure on the Centers for Medicare & Medicaid Services to make changes to its proposed final rules on the Protecting Access to Medicare Act (PAMA) have been ramped up, with two … [Read more...]
Palmetto Issues New Codes For BRCA, “Hotspot” Testing
January 15, 2016
Medicare fiscal intermediary Palmetto GBA quietly released new payment guidelines last month for several molecular tests under its MolDx program. Palmetto issued new codes related to BRCA testing, … [Read more...]
